Rapid peptide discovery and 'plug-and-play' technology could make personalised cancer vaccines reality

The new approach could help researchers quickly identify tumour-specific antigens recognised by cytotoxic T cells, generating a powerful, durable and highly specific response against an individual’s tumour. This could lead in turn to a quicker and easier way to generate effective, personalised cancer vaccines based on the identified antigens.

https://elifesciences.org/for-the-press/fa6ae7ab/rapid-peptide-discovery-and-plug-and-play-technology-could-make-personalised-cancer-vaccines-reality